Main Market : Pharmaceuticals
| High | 0.845 |
| Low | 0.835 |
| Volume | 26,300 |
| Volume (B/S) | 4,900 / 1,500 |
| Price Bid/Ask | 0.835 / 0.845 |
| 52w | 0.804 - 1.302 |
| ROE | 17.00 |
| P/E | 18 |
| EPS | 4.76 |
| DPS | 1.80 |
| DY | 2.16% |
| NTA | 0.2800 |
| P/B | 2.98 |
| RPS | 12.57 |
| PSR | 7 |
| Market Cap | 265.3M |
| Shares (mil) | 317.74 |
| QoQ YoY | RQoQ RYoY |
| RSI(14) | Neutral 43.3 |
| Stochastic(14) | Neutral 28.6 |
| Average Volume | 161,700 |
| Relative Volume | 0.2 |
| EPS | DPS | NTA | Revenue | P/L | Quarter | Q Date | Financial Year | Announced | QoQ% | YoY% | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.09 | 0.000 | 0.2800 | 10.20m | 3.46m | 3 | 2021-03-31 | 30 Jun, 2021 | 2021-05-18 | 14.7% | 27.1% | View |
| 1.28 | 1.800 | 0.2900 | 10.00m | 4.06m | 2 | 2020-12-31 | 30 Jun, 2021 | 2021-02-09 | 50.8% | 14.4% | View |
| 0.85 | 0.000 | 0.2900 | 9.05m | 2.69m | 1 | 2020-09-30 | 30 Jun, 2021 | 2020-11-16 | 45.2% | 44.6% | View |
| 1.54 | 0.000 | 0.2700 | 10.68m | 4.91m | 4 | 2020-06-30 | 30 Jun, 2020 | 2020-08-18 | 80.3% | 13% | View |
| 0.86 | 0.000 | 0.2600 | 8.78m | 2.72m | 3 | 2020-03-31 | 30 Jun, 2020 | 2020-05-21 | 23.2% | 33.5% | View |
| 1.12 | 0.550 | 0.2500 | 8.82m | 3.55m | 2 | 2019-12-31 | 30 Jun, 2020 | 2020-02-25 | 90.6% | 15.1% | View |
| 0.59 | 0.000 | 0.2500 | 5.99m | 1.86m | 1 | 2019-09-30 | 30 Jun, 2020 | 2019-11-27 | 67% | 119.9% | View |
| 1.77 | 0.000 | 0.2400 | 9.63m | 5.64m | 4 | 2019-06-30 | 30 Jun, 2019 | 2019-08-26 | 176.6% | 133.8% | View |
| 0.64 | 0.000 | 0.2300 | 7.24m | 2.04m | 3 | 2019-03-31 | 30 Jun, 2019 | 2019-05-16 | 33.8% | 47.8% | View |
| 0.99 | 0.500 | 0.2200 | 7.88m | 3.08m | 2 | 2018-12-31 | 30 Jun, 2019 | 2019-02-27 | 264.1% | 0% | View |
| 0.28 | 0.000 | 0.2300 | 4.81m | 846.00k | 1 | 2018-09-30 | 30 Jun, 2019 | 2018-11-29 | 64.9% | 0% | View |
| 1.49 | 0.000 | 0.1700 | 8.06m | 2.41m | 4 | 2018-06-30 | 30 Jun, 2018 | 2018-08-28 | 74.8% | 0% | View |
| 1.00 | 0.000 | 0.2400 | 4.75m | 1.38m | 3 | 2018-03-31 | 30 Jun, 2018 | 2018-07-12 | 0% | 0% | View |
| Announced | Financial Year | Subject | EX Date | Payment Date | Amount | Indicator | |
|---|---|---|---|---|---|---|---|
| 09 Feb 2021 | 30 Jun 2021 | Special Dividend | 25 Feb 2021 | 05 Mar 2021 | 0.0120 | Currency | View |
| 09 Feb 2021 | 30 Jun 2021 | Interim Dividend | 25 Feb 2021 | 05 Mar 2021 | 0.0060 | Currency | View |
| 16 Oct 2020 | 30 Jun 2020 | Final Dividend | 01 Dec 2020 | 09 Dec 2020 | 0.0088 | Currency | View |
| 25 Feb 2020 | 30 Jun 2020 | Interim Dividend | 09 Mar 2020 | 17 Mar 2020 | 0.0055 | Currency | View |
| 25 Oct 2019 | 30 Jun 2019 | Final Dividend | 11 Dec 2019 | 19 Dec 2019 | 0.0060 | Currency | View |
| 01 Mar 2019 | 30 Jun 2019 | Interim Dividend | 13 Mar 2019 | 29 Mar 2019 | 0.0050 | Currency | View |
| 29 Oct 2018 | 30 Jun 2018 | Final Dividend | 10 Dec 2018 | 19 Dec 2018 | 0.0180 | Currency | View |
| Announced | EX Date | Subject | Ratio |
|---|
No records
| Name | Price | Change | Volume | Gearing | Premium | Premium % | Maturity |
|---|
No warrants found.
Recent News
-
Temporary closure of Nova unit
PETALING JAYA: Nova Wellness Group Bhd’s unit Nova Laboratories Sdn Bhd will implement a temporary closure of its operations for seven days until July 18 following the discovery of several positive cases of Covid-19 infections among its factory workers.TheStar -
诺华药业子公司关厂7天
Nanyang -
Nova Wellness factory shut for one week after Covid-19 cases detected
TheEdge -
Call for Malaysia to liberalise solar power industry
Existing quotas are too small for market demandTheStar -
Kawan Food invests RM7.3m in solar PV system at Selangor HQ
TheEdge
Recent Announcements
-
OTHERS
NOVA WELLNESS GROUP BERHAD -TEMPORARILY CESSATION OF OPERATIONS FOR QUARANTINE DUE TO COVID-19 -
Change in Risk Committee - ENCIK SULAIMAN BIN HAJI AHMAD
-
Change in Remuneration Committee - MR SIM SENG LOONG @ TAI SENG
-
Change in Audit Committee - DR ABDUL MANAF BIN MOHAMAD RADZI
-
Change in Nomination Committee - DR ABDUL MANAF BIN MOHD RADZI
More analytics: